Alnylam Pharmaceuticals, Inc.

ALNY | $144.315 -0.58% -0.59% 700K

(0.0% 1d) (-1.5% 1m) (-31.0% 1y) (-0.5% 2d) (-0.5% 3d) (-2.2% 7d) (76.27% volume)
Earnings Calendar: 2024-02-15
Market Cap: $ 18,175,867,117
http://www.alnylam.com
Sec Filling | Patents | 1323 employees

(US) Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. The company was founded by John Kennedy Clarke, Paul R. Schimmel and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

glass genetic msa treatment

Drugs

GIVLAARI (givosiran sodium)
Onpattro (patisiran)
OXLUMO (lumasiran)

add to watch list Paper trade email alert is off

AngioDynamics, Inc.

ANGO | $6.26 2.29% 2.24% 480K

Health Technology

(0.0% 1d) (13.4% 1m) (-29.7% 1y) (0.0% 2d) (0.0% 3d) (-0.8% 7d) (-6.84% volume)
Earnings Calendar: 2024-04-04
Market Cap: $ 250,741,377
http://www.angiodynamics.com
Sec Filling | Patents | 800 employees

(US) AngioDynamics, Inc. engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage. thrombolytic, and venous products. The company was founded by Eamonn P. Hobbs in 1988 and is headquartered in Latham, NY.

add to watch list Paper trade email alert is off

Dynavax Technologies Corporation

DVAX | $11.78 3.88% 3.74% 9.3M

Health Technology

(0.0% 1d) (-3.0% 1m) (7.1% 1y) (4.1% 2d) (4.1% 3d) (0.9% 7d) (325.87% volume)
Earnings Calendar: 2024-02-22
Market Cap: $ 1,541,565,150
http://www.dynavax.com
Sec Filling | Patents | 231 employees

(US) Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development and commercialization of novel vaccines and immuno-oncology therapeutics. The firm focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.

vaccine cancer immunotherapy msa cpg 1018 plague vaccine

Drugs

HEPLISAV-B (Hepatitis B Vaccine (Recombinant) Adjuvanted)

add to watch list Paper trade email alert is off

Corcept Therapeutics Incorporated

CORT | $22.97 1.37% 1.35% 920K

Health Technology

(0.0% 1d) (-7.3% 1m) (2.2% 1y) (0.0% 2d) (0.0% 3d) (-0.9% 7d) (29.47% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 2,377,854,400
http://www.corcept.com
Sec Filling | Patents | 206 employees

(United States) Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.

hormone metabolic

add to watch list Paper trade email alert is off

Cutera, Inc.

CUTR | $1.95 -15.22% -17.95% 1.1M

Health Technology

(0.0% 1d) (-15.2% 1m) (-91.3% 1y) (0.0% 2d) (0.0% 3d) (-11.8% 7d) (13.32% volume)
Earnings Calendar: 2024-03-21
Market Cap: $ 38,890,556
http://www.cutera.com
Sec Filling | Patents | 447 employees

(US) Cutera, Inc. sells aesthetic medical equipment and services, and distributes skincare products, to medical practitioners. The firm designs, develops, manufactures, distributes and markets light and energy-based product platforms for use by physicians and other practitioners, enabling them to offer safe and effective aesthetic treatments to customers. Its products include enlighten, excel HR, excel V, excel V+, Juliet, Secret RF, truSculpt flex, truSculpt iD, truSculpt 3D and xeo. The company was founded by David A. Gollnick in August 1998 and is headquartered in Brisbane, CA.

energy aesthetic treatment 3d

add to watch list Paper trade email alert is off

Cytokinetics, Incorporated

CYTK | $67.49 0.73% 0.73% 1.5M

Health Technology

(0.0% 1d) (2.3% 1m) (76.2% 1y) (0.0% 2d) (0.0% 3d) (-0.7% 7d) (65.16% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 7,057,840,112
http://www.cytokinetics.com
Sec Filling | Patents | 156 employees

Cytokinetics, Inc. operates as a biopharmaceutical company, which focuses on the discovery and development of muscle activators as potential treatment for debilitating diseases. It conducts a Phase 2 clinical trials program for tirasemtiv, including a Phase 2b clinical trial in patients with ALS, known as BENEFIT-ALS (Blinded Evaluation of Neuromuscular Effects and Functional Improvement with Tirasemtiv in ALS). The company was founded on August 5, 1997 and is headquartered in South San Francisco, CA.

clinical trials msa treatment als

add to watch list Paper trade email alert is off

MannKind Corporation

MNKD | $4.19 2.7% 2.63% 1.8M

Health Technology

(0.0% 1d) (-12.2% 1m) (2.7% 1y) (0.0% 2d) (2.0% 3d) (1.5% 7d) (-26.7% volume)
Earnings Calendar: 2024-02-22
Market Cap: $ 1,134,146,250
http://www.mannkindcorp.com
Sec Filling | Patents | 233 employees

(United States) MannKind Corp. is a biopharmaceutical company. It focuses on the discovery, development and, commercialization of therapeutic products for diseases, such as diabetes and cancer. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Westlake Village, CA.

cancer diabetes diabetic

Drugs

Afrezza (Insulin Human)

add to watch list Paper trade email alert is off

NeuroMetrix, Inc.

NURO | News | $4.28 17.26% 14.72% 250K

Health Technology

(0.0% 1d) (6.4% 1m) (196.6% 1y) (19.0% 2d) (21.3% 3d) (23.0% 7d) (Infinity% volume)
Earnings Calendar:
Market Cap: $ 8,502,391
http://www.neurometrix.com
Sec Filling | Patents | 23 employees

(US) NeuroMetrix, Inc. is a healthcare company, which engages in the research, development, and trade of medical equipment and consumables. It offers an over-the-counter wearable therapeutic device for chronic pain, the Quell Health Cloud, DPNCheck, and pain management devices to treat chronic pain, nerve diseases, and sleep disorder. The company was founded by Shai N. Gozani in June 1996 and is headquartered in Woburn, MA.

chronic pain pain relief

add to watch list Paper trade email alert is off

NuVasive, Inc.

NUVA | $39.75 -2.24% -2.29% 0

Health Technology

(0.0% 1d) (0.0% 1m) (-7.4% 1y) (0.0% 2d) (-2.2% 3d) (0.0% 7d) (156.26% volume)
Earnings Calendar: 2023-11-09
Market Cap: $ 2,084,854,388
http://www.nuvasive.com
Sec Filling | Patents | 2800 employees

(US) NuVasive, Inc. engages in the development of minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery. It offers cervical and spine fusion surgery, cervical plating, and posterior fixation products. The company was founded by Alexis V. Lukianov on July 21, 1997 and is headquartered in San Diego, CA.

add to watch list Paper trade email alert is off